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Abstract  
Condyloma acuminata represents an epidermal manifestation, associated with the epidermotropic human 
papillomavirus (HPV). They have been reported as the most common sexually transmitted disease, with 
prevalence exceeding 50%, increased up to 4 times, within the last two decades, as the most common side of 
affection are the penis, vulva, vagina, cervix, perineum, and perianal area, with increased prevalence in young, 
sexually active individuals.  Increased attention should be focused on lesions, caused by types, with moderate 
(33, 35, 39, 40, 43, 45, 51-56, 58) or high risk potential (types 16, 18) for malignant transformation, leading to 
further development of cancers of anus, vagina, vulva and penis, as well as cancers of the head and neck . A 
provident of coexistence of many of these types in the same patient could be seen in approximately 10-15% of 
patients, as the lack of adequate information on the oncogenic potential of many other types complicated the 
treatment and the further outcome. Although the variety of treatment options, genital condylomata acuminata still 
show high recurrent rate to destructive topical regiments, because of the activation of the viruses at some point, 
which emphasise the importance of virus- eradication, instead only of the topical destruction of the lesions.  
Despite decreasing the recurrent rate, the most important goal of immunisation is the reduction of the incidence of 
HPV-associated squamous cell carcinomas using either the quadrivalent (Silgard/Gardasil) or the bivalent 
(Cervarix) HPV (human papillomavirus) vaccine. We present a patient with periurethral condylomata acuminate, 
who refused performing of a biopsy for determining the virus type, as we want to emphasize the importance of the 
virus - treatment in all cases of genital warts, instead only of topical destruction of the lesions, not only because of 
the recurrence incidence rate, but also because of the well - known oncogenic potential of some HPV - types, as 
well as the unknown potential of various underestimated types, in contrast. 
 
 
 
 
 
 
 
 
 
Introduction 
 
Condyloma acuminata represents an 
epidermal manifestation, associated with the 
epidermotropic human papillomavirus (HPV) [1]. HPV 
is most often acquired via sexual transmission in 
sexually active individuals, vertical transmission or 
extragenital contact in younger patients, rarely in 
children [2]. They have been reported as the most 
common sexually transmitted disease, with 
prevalence exceeding 50%, increased up to 4 times, 
within the last two decades [2]. The most common site 
affected are the penis, vulva, vagina, cervix, 
perineum, and perianal area, with increased 
prevalence in young, sexually active individuals [1[[2]. 
Uncommon, but also reported sides of invasion are 
oropharynx, larynx, and trachea [2]. Up to 90% of the 
genital warts are related to HPV 6 and 11 types, with 
no neoplastic potential [2].  Increased attention should 
be focused on lesions, caused by types, with 
moderate (33, 35, 39, 40, 43, 45, 51-56, 58) or high 
risk potential (types 16, 18) for malignant 
transformation, leading to further development of 
cancers of anus, vagina, vulva and penis, as well as 
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cancers of the head and neck  [1][3]. A provident of 
coexistence of many of these types in the same 
patient could be seen in approximately 10-15% of 
patients, as the lack of adequate information on the 
oncogenic potential of many other types complicated 
the treatment and the further outcome [3]. 
 
 
Case Report 
 
A 26-year-old Caucasian, otherwise healthy 
male patient presented with 6 - months history of 
papillomatous lesions, affecting his glans penis and 
orificium urethrae was reported. No accompanying 
diseases, neither medication was reported. Patient-
reported brave heterosexual behaviour and 
promiscuity. The papillomatous lesion was observed 
within the clinical examination, located on gland penis, 
exclusively affecting the paraurethral area, measuring 
approximately 3 cm in diameter (Fig. 1). 
 
Figure 1: a, b Papillomatous lesion, located on gland penis, 
affecting orificium urethrae in a 26-year-old male patient 
 
HPV - DNA testing with PCR for high-risk 
HPV viruses was not performed, because of the 
patient’s refusal for biopsy. Paraclinical examinations 
did not reveal any abnormalities. HIV, HBsAg, anti -
HBC and TPHA test were negative. The diagnosis of 
condylomata acuminata was made. 
Topical treatment with imiquimod 5% was 
initiated. Subsequent laser therapy with pulsed dye 
laser was planned for a total resolution of the 
symptoms if such was not achieved with topical 
treatment. A vaccination with anti - HPV vaccine was 
also planned for the later stage for prevention of 
further relapses.  
 
 
Discussion 
 
Conventional treatment options for 
condylomata acuminata vary between chemical 
(podophyllotoxin) and physical destruction methods, 
which are painful and less effective, with high 
recurrence rates [1]. Intraurethral fluorouracil and 
lidocaine instillation have also been reported with a 
variable degree of effectiveness [1].  The use of 
immunotherapies is preferred recently, including 
topical application of imiquimod 5% cream, cimetidine 
and intralesional or systemic interferon [4]. 
Laser therapy has also been applied with 
satisfactory therapeutic response in otherwise 
resistant or recurrent lesions [4]. Application of a 
Pulsed dye laser-therapy is reported as a safe, 
effective, satisfactory and less traumatic compared to 
other options for treatment of genital warts [4]. 
Ultrasonic surgical aspiration, electrocautery 
fulguration and cryosurgery have been also used 
successfully [1][4]. 
Although various treatment options, genital 
condylomata acuminata still show high recurrent rate 
to topical destructive treatment options, because of 
the activation of the viruses at some point, which 
emphasize the importance of virus- eradication, 
instead only of the topical destruction of the lesions 
[3].  Despite decreasing the recurrent rate, the most 
important goal of immunization is the reduction of the 
incidence of HPV-associated squamous cell 
carcinomas using either the quadrivalent 
(Silgard/Gardasil) or the bivalent (Cervarix) HPV 
(human papillomavirus) vaccine [3]. 
We present a patient with periurethral and 
intraurethral condylomata acuminate, which refused 
performing of a biopsy for determining the virus type, 
as we want to emphasize the important of the virus- 
treatment in all cases of genital warts, instead only of 
topical destruction of the lesions, not only because of 
the recurrence incidence, but also because of the 
well-known oncogenic potential of some HPV-types, 
but also the unknown potential of various 
underestimated types, in contrast. 
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